Deilson Elgui de Oliveira

Biomédico pelo Instituto de Biociências de Botucatu (1997) da Universidade Estadual Paulista "Júlio de Mesquita Filho" (UNESP). Doutor em Patologia pela Faculdade de Medicina de Botucatu (FMB; 2002), UNESP, com pós-doutoramento na Weill Cornell Medical College, EUA (2008-2009). Atua na UNESP em regime de tempo integral e dedicação exclusiva como docente junto ao Departamento de Patologia da FMB (2003-*) e como pesquisador do Instituto de Biotecnologia da UNESP (2015-*). Possui experiência em Patologia Humana, com ênfase em Cancerologia e Patologia Molecular. Principais temas de trabalho: biologia dos cânceres, carcinogênese viral e carcinogênese ambiental. Realizou estágios de curta duração em diversas instituições no exterior, incluindo Children's & Women?s Hospital / University of British Columbia (Vancouver, BC, Canada; 2004); Texas Children?s Hospital / Baylor College of Medicine (Houston, TX, USA; 2005); Hillman Cancer Center / University of Pittsburgh (Pittsburgh, PA, USA; 2006), Weill Medical College / Cornell University (New York, NY, USA; 2007; 2008-2009) e Whitehead Institute / Massachusetts Institute of Technology (Cambridge, MA, USA; 2012). É coordenador e Investigador Principal do Grupo de Estudos em Carcinogênese Viral e Biologia dos Cânceres (ViriCan - http://virican.net). LINKS: ORCID: https://orcid.org/0000-0001-5562-9648; Publons/ResearchID: http://goo.gl/Foh7k5; Google Scholar - http://goo.gl/wdGbi; FAPESP: http://goo.gl/DTTxT.

Dr. Elgui de Oliveira has a major in Biomedical Sciences (1997) from the School of Biosciences of Botucatu (IBB), São Paulo State University (UNESP), and a PhD degree in Pathology from Medical School of Botucatu (2002), UNESP. Fully dedicated to teaching and research at UNESP, he is professor of pathology at the Medical School of Botucatu (FMB), and researcher at the Institute of Biotechnology (IBTEC). He has expertise in human pathology, with focus on oncology and molecular pathology; his major areas of research are cancer biology, viral carcinogenesis, and environmental carcinogenesis. Other areas of interest include education for biosciences & healthcare careers, entrepreneurship and innovation, as well as information technologies (IT) applied to education, research, and technological development. Dr. Elgui de Oliveira has attended trainings in world-class institutions in North America, including Children's & Women?s Hospital / University of British Columbia (Vancouver, BC, Canada; 2004); Texas Children?s Hospital / Baylor College of Medicine (Houston, TX, USA; 2005); Hillman Cancer Center / University of Pittsburgh (Pittsburgh, PA, USA; 2006), Weill Medical College / Cornell University (WMCCU; New York, NY, USA; 2007), and the Whitehead Institute / Massachusetts Institute of Technology (Cambridge, MA, USA; 2012). He is the principal investigator of the Viral Carcinogenesis and Cancer Biology Research Group (ViriCan - http://ViriCan.net) since its foundation, in 2002. More information: ORCID: https://orcid.org/0000-0001-5562-9648; Publons/ResearchID: http://goo.gl/Foh7k5; Google Scholar - http://goo.gl/wdGbi; FAPESP: http://goo.gl/DTTxT.